Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aegis Capital Corp. is a full-service investment bank and brokerage firm founded in 1984 and headquartered in New York City. The firm is a prominent player in the healthcare and life sciences sectors, frequently serving as a lead underwriter for initial public offerings (IPOs), follow-on offerings, and private placements for emerging growth companies. Aegis provides a comprehensive suite of services, including investment banking, wealth management, and strategic advisory, with a particular expertise in the micro-cap and small-cap markets. By bridging the gap between institutional investors and developing biotech firms, Aegis plays a critical role in the capitalization of the life sciences industry. The firm operates multiple offices across the United States and maintains a global reach through its diverse client base.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aegis Capital.